All Stories

  1. Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults

    Article • Psychiatric Services, September 2021, American Psychiatric Association

    Dr marcela v horvitz-lennon

  2. Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia

    Article • Psychiatric Services, January 2018, American Psychiatric Association

    Dr marcela v horvitz-lennon

  3. The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia

    Article • American Journal of Psychiatry, May 2017, American Psychiatric Association

    Dr marcela v horvitz-lennon

  4. The Effect of Race-Ethnicity on the Comparative Effectiveness of Clozapine Among Medicaid Beneficiaries

    Article • Psychiatric Services, March 2013, American Psychiatric Association

    Dr marcela v horvitz-lennon

  5. Care For Veterans With Mental And Substance Use Disorders: Good Performance, But Room To Improve On Many Measures

    Article • Health Affairs, October 2011, Health Affairs

    Dr marcela v horvitz-lennon